Search
Search

| Catalog Number | No. of Reactions |
|---|---|
| A54103 | 32 Reactions |
The Oncomine Dx Express Test is an in vitro diagnostic assay that uses targeted next-generation sequencing (NGS) to detect biomarkers across 46 genes. The Oncomine™ Dx Express Test is a qualitative in vitro diagnostic test that uses targeted next generation sequencing (NGS) technology to detect substitutions, insertions, and deletions in 42 genes from DNA, copy number variants (CNVs) in 10 genes from DNA, and fusions or splice variants in 18 genes from RNA isolated from formalin-fixed, paraffin-embedded (FFPE) tumor samples using the Genexus™ Dx Integrated Sequencer.
The test is designed for use with the Genexus Dx System. Its fully automated workflow—from sample preparation to results—can be completed in as little 24 hours, supporting timely decision-making in clinical practice.
Additional products that are required to complete the Oncomine Dx Express Test workflow include:
*Not available in the U.S.